South African-based JSE Limited listed Aspen is a supplier of branded and generic pharmaceuticals in approximately 100 countries across the globe and of consumer and nutritional products in selected territories.

Aspen is represented in South Africa, Australia, Hong Kong, Philippines, Kenya, Tanzania, Uganda, Dubai, Germany, Ireland, Mauritius, Brazil, Mexico and Venezuela. The Group has 18 manufacturing facilities at 13 sites on 6 continents.

Aspen has production capabilities for a wide variety of product types including tablets, capsules, steriles, injectables, oral contraceptives, nutritional products, lyophilised vials, cytotoxics, suppositories, vials, form-filled seals, liquids, semi-solids and specialist active pharmaceutical ingredients.

 

Aspen Generics

Which one's the generic?
South Africa's generic
brand of choice.
Aspen Generics

Investor Relations

Aspen share prices - click here

Aspen interim results for the six months ended 31 December 2011:

Interim results presentation  - click here (7 Mb)

Ongeouditeerde tussentydse finansiële resultate - sien hier (416 kb)

Unaudited interim financial results - click here (423 Kb)

Unaudited interim financial results booklet - click here (976 kb)

Aspen financial year ended 30 June 2011:
click here to view:

Aspen year end results presentation;
Reviewed preliminary results; and
Nagegane voorlopige resultate 

Aspen 2011 Annual Report  - click here for link; click here for pdf (6.4 Mb)